ValenTx is an early-stage medical device company developing a non-surgical, implantable medical therapy to treat obesity and obesity-related metabolic disorders such as type-2 diabetes and hypertension. It offers a non-surgical, endoluminal bypass device that builds on the success of established medical interventions, resulting in least-invasive therapy.